Patents by Inventor Matthew T. Manlove

Matthew T. Manlove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligonucleotides specific for the MOMP gene sequence and methods for the detection of Chlamydia trachomatis
    Patent number: 5846785
    Abstract: The present invention relates to oligonucleotide probes useful in detecting, e.g. by hybridization or the ligase chain reaction, Chlamydia trachomatis DNA in the presence of other related DNA. The present invention is also directed to methods of detecting Chlamydia trachomatis organisms in a sample using the ligase chain reaction.
    Type: Grant
    Filed: June 23, 1997
    Date of Patent: December 8, 1998
    Assignee: Abbott Laboratories
    Inventors: John D. Burczak, John J. Carrino, Paul A. Klonowski, Matthew T. Manlove, Ronald L. Marshall, Edward K. Pabich, John A. Salituro
  • Materials and methods for the detection of mycobacterium tuberculosis
    Patent number: 5786149
    Abstract: The present invention is directed to oligonucleotides useful in detection, e.g., by ligase chain reaction (LCR) of target DNA from Mycobacterium tuberculosis. The present invention is also directed to methods of detecting target DNAs from Mycobacterium tuberculosis.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: July 28, 1998
    Assignee: Abbott Laboratories
    Inventors: Gregor W. Leckie, Alan H. Davis, Ingrid E. Semple-Facey, Matthew T. Manlove, Natalie A. Solomon
  • Oligonucleotides and methods for the detection of Chlamydia trachomatis
    Patent number: 5756298
    Abstract: The present invention relates to oligonucleotide probes useful in detecting, e.g. by hybridization or the ligase chain reaction, Chlamydia trachomatis DNA in the presence of other related DNA. The present invention is also directed to methods of detecting Chlamydia trachomatis organisms in a sample using the ligase chain reaction.
    Type: Grant
    Filed: September 5, 1996
    Date of Patent: May 26, 1998
    Assignee: Abbott Laboratories
    Inventors: John D. Burczak, John J. Carrino, Paul A. Klonowski, Matthew T. Manlove, Ronald L. Marshall, Edward K. Pabich, John A. Salituro
  • Materials and methods for the detection of Mycobacterium tuberculosis
    Patent number: 5631130
    Abstract: The present invention is directed to oligonucleotides useful in detection, e.g., by ligase chain reaction (LCR) of target DNA from Mycobacterium tuberculosis. The present invention is also directed to methods of detecting target DNAs from Mycobacterium tuberculosis.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: May 20, 1997
    Assignee: Abbott Laboratories
    Inventors: Gregor W. Leckie, Alan H. Davis, Ingrid E. Semple-Facey, Matthew T. Manlove, Natalie A. Solomon
  • Oligonucleotides and methods for the detection of chlamydia trachomatis
    Patent number: 5601978
    Abstract: The present invention relates to oligonucleotide probes useful in detecting, e.g. by hybridization or the ligase chain reaction, Chlamydia trachomatis DNA in the presence of other related DNA. The present invention is also directed to methods of detecting Chlamydia trachomatis organisms in a sample using the ligase chain reaction.
    Type: Grant
    Filed: September 3, 1993
    Date of Patent: February 11, 1997
    Assignee: Abbott Laboratories
    Inventors: John D. Burczak, John J. Carrino, Paul A. Klonowski, Matthew T. Manlove, Ronald L. Marshall, Edward K. Pabich, John A. Salituro